Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj… was recalled on September 25, 2026 in cooperation with the U.S. Food and Drug Administration because lack of assurance of sterility..
Tirzepatide/Niacinamide 2mL vial (40 MG per Vial) Inj 20mg/2mg/mL, RX Only, Houston RX LLC, 15430 Vantage Parkway E STE 220, Houston, TX 77032.
Lot# TZN-080326-20/2-2, Beyond Use Date: 12/01/2026.
Units affected: 64 vials
Where it was sold: Nationwide in the USA.
Compare the codes above against the label on your product — usually on the bottom, the back panel, or the packaging. If your unit isn't listed, it is not part of this recall.
Lack of assurance of sterility.
Class II means the product might cause a temporary or medically reversible health problem; the chance of serious harm is remote.
Stop using the product. Return it to the place of purchase for a refund, or dispose of it. Contact the recalling firm with questions.
Contact: Recalling firm: Houston Rx LLC
Not sure what you're entitled to? Read our guide: what to do if your product is recalled.
Always confirm details on the official notice from the U.S. Food and Drug Administration before acting.
View official notice →The recalled hair regrowth products contain minoxidil, which must be in child-resistant packaging, as required by the Poison Prevention Packaging Act. The bottle is not child-resistant, posing a risk of serious injury or death from poisoning if the contents are ingested by young children.
The recalled bicycles' front lock nut can loosen during use, causing the front wheel to dislodge or loosen over time, posing a crash hazard.
Presence of Foreign Tablets/Capsules
Foreign object: May contain pieces of metal
Be the first to know when products like this are recalled. Free weekly digest, unsubscribe anytime.